세계의 수면 보조제 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide Sleep Aids Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Sleep Aids Market from 2024 to 2033.

Key Insights:

• Sleep Aids Market Size (2024E): USD 29.6 Billion
• Projected Market Value (2033F): USD 43.2 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 4.3%

Sleep Aids Market - Report Scope:

Sleep aids play a crucial role in managing various sleep disorders, including insomnia, sleep apnea, restless legs syndrome, and other conditions affecting sleep quality. These aids encompass a spectrum of products and therapies designed to improve sleep patterns, enhance sleep duration, and promote overall sleep health. The sleep aids market caters to diverse demographics through pharmaceuticals, medical devices, and behavioral therapies, addressing both chronic and occasional sleep issues.

Market Growth Drivers:

The global sleep aids market is driven by several key factors, including increasing prevalence of sleep disorders due to lifestyle changes, stress, and aging population. Rising awareness about the importance of sleep hygiene and its impact on overall health is amplifying demand for effective sleep aids. Technological advancements in sleep tracking devices, wearable technologies, and personalized sleep therapies are enhancing treatment outcomes and patient adherence. Moreover, the growing acceptance of telemedicine and digital health platforms is facilitating remote access to sleep evaluation and treatment, thereby expanding market reach.

Market Restraints:

Despite promising growth prospects, the sleep aids market faces challenges related to regulatory approvals, safety concerns associated with long-term use of certain medications, and variable efficacy of non-pharmacological interventions. Stringent regulations governing the approval and marketing of sleep aid products impose compliance burdens on manufacturers and healthcare providers, influencing market entry strategies and operational costs. Limited reimbursement coverage for sleep disorder treatments in some regions also poses a barrier to market penetration, particularly in emerging economies.

Market Opportunities:

The sleep aids market presents significant growth opportunities driven by technological innovations in sleep diagnostics and treatment modalities. Advancements in neurostimulation devices, cognitive behavioral therapies, and novel pharmacological agents are expanding the therapeutic options available to clinicians and patients. Furthermore, the integration of artificial intelligence (AI) and big data analytics in sleep research is facilitating personalized treatment plans and predictive insights into sleep disorders. Strategic collaborations between healthcare providers, technology developers, and regulatory bodies are essential to capitalize on emerging opportunities and navigate the evolving regulatory landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the sleep aids market globally?
• Which types of sleep aids and therapeutic approaches are gaining traction across different demographics?
• How are technological advancements reshaping the competitive landscape of the sleep aids market?
• Who are the key players contributing to the sleep aids market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global sleep aids market?

Competitive Intelligence and Business Strategy:

Leading players in the global sleep aids market, including pharmaceutical companies, medical device manufacturers, and digital health innovators, focus on innovation, clinical research, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop next-generation sleep aid products, such as advanced pharmaceutical formulations, wearable sleep monitors, and AI-driven sleep management platforms. Collaborations with sleep clinics, academic institutions, and regulatory agencies facilitate product development, market access, and patient education initiatives. Moreover, emphasis on evidence-based practice and patient-centric care fosters market growth and improves treatment outcomes in the dynamic sleep aids landscape.

Key Companies Profiled:

• ResMed Inc.
• Koninklijke Philips N.V.
• Merck & Co. Inc.
• Drive DeVilbiss Healthcare LLC
• GlaxoSmithKline Plc.
• Fisher & Paykel Healthcare Limited
• Sanofi SA
• Pfizer Inc.

Key Segments Covered in Global Industry Research

Product:

• Drugs
• Devices

Indication:

• Insomnia
• Sleep Deprivation
• Narcolepsy
• Sleep Apnea

Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• e commerce
• Drug Stores

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Market Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Regulations
• 4.3. Disease Epidemiology
• 4.4. Pipeline Assessment
• 4.5. Recent Product launches/ Approvals
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Sleep Market Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increase in R&D Spending
  • 5.2.2. Rising Population with Sleep Disorders
  • 5.2.3. Growing Lifestyle Disease Prevalence
  • 5.2.4. Cost of Products
  • 5.2.5. Product Features
  • 5.2.6. Advancements in Technology
  • 5.2.7. Changes in Regulatory Policies
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Indication
  • 6.1.3. By Distribution Channel
  • 6.1.4. By Country
• 6.2. 2024 Market Scenario

7. Global Sleep Aids Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
  • 8.3.1. Drugs
    • 8.3.1.1. Insomnia Treatment Drugs
      • 8.3.1.1.1. Doxepin Hydrochloride
      • 8.3.1.1.2. Eszopiclone
      • 8.3.1.1.3. Ramelteon
      • 8.3.1.1.4. Triazolam
      • 8.3.1.1.5. Zaleplon
      • 8.3.1.1.6. Quazepam
      • 8.3.1.1.7. Others
    • 8.3.1.2. Narcolepsy Treatment Drugs
      • 8.3.1.2.1. Modafinil
      • 8.3.1.2.2. Sodium Oxybate
      • 8.3.1.2.3. Armodafinil
      • 8.3.1.2.4. Others
  • 8.3.2. Devices
    • 8.3.2.1. CPAP Devices
    • 8.3.2.2. BiPAP Devices
    • 8.3.2.3. APAP Devices
  • 8.3.3. Others
    • 8.3.3.1. Mattresses and Pillows
    • 8.3.3.2. Chin Straps
    • 8.3.3.3. Mouth Pieces and Nasal Devices
• 8.4. Market Attractiveness Analysis By Product

9. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
  • 9.3.1. Insomnia
  • 9.3.2. Sleep Deprivation
  • 9.3.3. Narcolepsy
  • 9.3.4. Sleep Apnea
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis By Indication

10. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
  • 10.3.1. Hospital Pharmacies
  • 10.3.2. Retail Pharmacies
  • 10.3.3. e commerce
  • 10.3.4. Drug Stores
  • 10.3.5. Others
• 10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Indication
  • 12.3.4. By Distribution Channel
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Indication
  • 12.4.4. By Distribution Channel
• 12.5. Market Trends
• 12.6. Drivers and Restraints - Impact Analysis
• 12.7. Key Players - Intensity Mapping
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Sleep Aids Market Analysis
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By Indication
      • 12.8.1.2.3. By Distribution Channel
  • 12.8.2. Canada Sleep Aids Market Analysis
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By Indication
      • 12.8.2.2.3. By Distribution Channel

13. Latin America Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Mexico
    • 13.3.1.2. Brazil
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Indication
  • 13.3.4. By Distribution Channel
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Indication
  • 13.4.4. By Distribution Channel
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Mexico Sleep Aids Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Indication
      • 13.8.1.2.3. By Distribution Channel
  • 13.8.2. Brazil Sleep Aids Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Indication
      • 13.8.2.2.3. By Distribution Channel
  • 13.8.3. Argentina Sleep Aids Market Analysis
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By Indication
      • 13.8.3.2.3. By Distribution Channel

14. Europe Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By Distribution Channel
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Germany Sleep Aids Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Indication
      • 14.8.1.2.3. By Distribution Channel
  • 14.8.2. Italy Sleep Aids Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Indication
      • 14.8.2.2.3. By Distribution Channel
  • 14.8.3. France Sleep Aids Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Indication
      • 14.8.3.2.3. By Distribution Channel
  • 14.8.4. U.K. Sleep Aids Market Analysis
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.4.2.1. By Product
      • 14.8.4.2.2. By Indication
      • 14.8.4.2.3. By Distribution Channel
  • 14.8.5. Spain Sleep Aids Market Analysis
    • 14.8.5.1. Introduction
    • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.5.2.1. By Product
      • 14.8.5.2.2. By Indication
      • 14.8.5.2.3. By Distribution Channel
  • 14.8.6. BENELUX Sleep Aids Market Analysis
    • 14.8.6.1. Introduction
    • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.6.2.1. By Product
      • 14.8.6.2.2. By Indication
      • 14.8.6.2.3. By Distribution Channel
  • 14.8.7. Russia Sleep Aids Market Analysis
    • 14.8.7.1. Introduction
    • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.7.2.1. By Product
      • 14.8.7.2.2. By Indication
      • 14.8.7.2.3. By Distribution Channel

15. East Asia Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Indication
  • 15.4.4. By Distribution Channel
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. China Sleep Aids Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Indication
      • 15.8.1.2.3. By Distribution Channel
  • 15.8.2. Japan Sleep Aids Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Indication
      • 15.8.2.2.3. By Distribution Channel
  • 15.8.3. South Korea Sleep Aids Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Indication
      • 15.8.3.2.3. By Distribution Channel

16. South Asia Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By Distribution Channel
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. India Sleep Aids Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Indication
      • 16.8.1.2.3. By Distribution Channel
  • 16.8.2. Indonesia Sleep Aids Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Indication
      • 16.8.2.2.3. By Distribution Channel
  • 16.8.3. Malaysia Sleep Aids Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Indication
      • 16.8.3.2.3. By Distribution Channel
  • 16.8.4. Thailand Sleep Aids Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Indication
      • 16.8.4.2.3. By Distribution Channel

17. Oceania Sleep Aids Market 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Indication
  • 17.4.4. By Distribution Channel
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Australia Sleep Aids Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Indication
      • 17.8.1.2.3. By Distribution Channel
  • 17.8.2. New Zealand Sleep Aids Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Indication
      • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkey
    • 18.3.1.3. North Africa
    • 18.3.1.4. South Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Indication
  • 18.4.4. By Distribution Channel
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. GCC Countries Sleep Aids Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Indication
      • 18.8.1.2.3. By Distribution Channel
  • 18.8.2. Turkey Sleep Aids Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Indication
      • 18.8.2.2.3. By Distribution Channel
  • 18.8.3. South Africa Sleep Aids Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Indication
      • 18.8.3.2.3. By Distribution Channel
  • 18.8.4. North Africa Sleep Aids Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Indication
      • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Benchmarking
• 20.3. Competition Deep Dive
  • 20.3.1. ResMed Inc.
    • 20.3.1.1. Overview
    • 20.3.1.2. Product Portfolio
    • 20.3.1.3. Sales Footprint
    • 20.3.1.4. Key Financials
    • 20.3.1.5. SWOT Analysis
    • 20.3.1.6. Strategy Overview
      • 20.3.1.6.1. Marketing Strategy
      • 20.3.1.6.2. Product Strategy
      • 20.3.1.6.3. Channel Strategy
  • 20.3.2. Koninklijke Philips N.V.
    • 20.3.2.1. Overview
    • 20.3.2.2. Product Portfolio
    • 20.3.2.3. Sales Footprint
    • 20.3.2.4. Key Financials
    • 20.3.2.5. SWOT Analysis
    • 20.3.2.6. Strategy Overview
      • 20.3.2.6.1. Marketing Strategy
      • 20.3.2.6.2. Product Strategy
      • 20.3.2.6.3. Channel Strategy
  • 20.3.3. Merck & Co. Inc.
    • 20.3.3.1. Overview
    • 20.3.3.2. Product Portfolio
    • 20.3.3.3. Sales Footprint
    • 20.3.3.4. Key Financials
    • 20.3.3.5. SWOT Analysis
    • 20.3.3.6. Strategy Overview
      • 20.3.3.6.1. Marketing Strategy
      • 20.3.3.6.2. Product Strategy
      • 20.3.3.6.3. Channel Strategy
  • 20.3.4. Drive DeVilbiss Healthcare LLC
    • 20.3.4.1. Overview
    • 20.3.4.2. Product Portfolio
    • 20.3.4.3. Sales Footprint
    • 20.3.4.4. Key Financials
    • 20.3.4.5. SWOT Analysis
    • 20.3.4.6. Strategy Overview
      • 20.3.4.6.1. Marketing Strategy
      • 20.3.4.6.2. Product Strategy
      • 20.3.4.6.3. Channel Strategy
  • 20.3.5. GlaxoSmithKline Plc.
    • 20.3.5.1. Overview
    • 20.3.5.2. Product Portfolio
    • 20.3.5.3. Sales Footprint
    • 20.3.5.4. Key Financials
    • 20.3.5.5. SWOT Analysis
    • 20.3.5.6. Strategy Overview
      • 20.3.5.6.1. Marketing Strategy
      • 20.3.5.6.2. Product Strategy
      • 20.3.5.6.3. Channel Strategy
  • 20.3.6. Fisher & Paykel Healthcare Limited
    • 20.3.6.1. Overview
    • 20.3.6.2. Product Portfolio
    • 20.3.6.3. Sales Footprint
    • 20.3.6.4. Key Financials
    • 20.3.6.5. SWOT Analysis
    • 20.3.6.6. Strategy Overview
      • 20.3.6.6.1. Marketing Strategy
      • 20.3.6.6.2. Product Strategy
      • 20.3.6.6.3. Channel Strategy
  • 20.3.7. Sanofi SA
    • 20.3.7.1. Overview
    • 20.3.7.2. Product Portfolio
    • 20.3.7.3. Sales Footprint
    • 20.3.7.4. Key Financials
    • 20.3.7.5. SWOT Analysis
    • 20.3.7.6. Strategy Overview
      • 20.3.7.6.1. Marketing Strategy
      • 20.3.7.6.2. Product Strategy
      • 20.3.7.6.3. Channel Strategy
  • 20.3.8. Pfizer Inc
    • 20.3.8.1. Overview
    • 20.3.8.2. Product Portfolio
    • 20.3.8.3. Sales Footprint
    • 20.3.8.4. Key Financials
    • 20.3.8.5. SWOT Analysis
    • 20.3.8.6. Strategy Overview
      • 20.3.8.6.1. Marketing Strategy
      • 20.3.8.6.2. Product Strategy
      • 20.3.8.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology